Accumulated lines of evidence have shown that ADAM28 expression was strikingly up-regulated in several human cancers [16], such as non-small cell lung cancer [17–19], breast cancer [20], bladder cancer [21] and chronic lymphocytic leukemia [22]. This evidence concerns the gene ADAM28 and non-small cell lung carcinoma.